Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04921358
Title Tislelizumab in Combination With Sitravatinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors BeiGene

lung non-small cell carcinoma



Sitravatinib + Tislelizumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU

Additional content available in CKB BOOST